Financial reports
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
5 May 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
16 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
Current reports
8-K
Entry into a Material Definitive Agreement
22 Dec 23
8-K
Cost Associated with Exit or Disposal Activities
2 Oct 23
8-K
Termination of a Material Definitive Agreement
15 Sep 23
8-K
Other Events
25 Jul 23
8-K
Departure of Directors or Certain Officers
7 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Jun 23
8-K
Departure of Directors or Certain Officers
10 Apr 23
8-K
SQZ Biotechnologies Receives Notice Regarding Continued Listing Standards From the New York Stock Exchange
18 Jan 23
8-K
Designation Represents Potential to Bring Important New Therapy to Patients Earlier
6 Dec 22
Registration and prospectus
15-12G
Securities registration termination
4 Jan 24
POS AM
Prospectus update (post-effective amendment)
30 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Nov 23
25-NSE
Exchange delisting
19 Jul 23
S-3
Shelf registration
12 Nov 21
424B4
Prospectus supplement with pricing info
12 Feb 21
S-1
IPO registration
9 Feb 21
DRS
Draft registration statement
1 Feb 21
DRSLTR
Correspondence regarding draft registration statement
29 Jan 21
S-8
Registration of securities for employees
30 Oct 20
Proxies
DEFM14A
Proxy related to merger
23 Jan 24
PREM14A
Preliminary proxy related to merger
12 Jan 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
PRE 14A
Preliminary proxy
10 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
DEFA14A
Additional proxy soliciting materials
26 Apr 21
DEF 14A
Definitive proxy
26 Apr 21
Other
EFFECT
Notice of effectiveness
4 Dec 23
EFFECT
Notice of effectiveness
19 Nov 21
CORRESP
Correspondence with SEC
16 Nov 21
UPLOAD
Letter from SEC
15 Nov 21
EFFECT
Notice of effectiveness
12 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
UPLOAD
Letter from SEC
8 Feb 21
EFFECT
Notice of effectiveness
30 Oct 20
SEC STAFF
SEC staff action: Order
30 Oct 20
Ownership
SC 13G/A
AMERICAN INTERNATIONAL GROUP, INC.
13 Feb 24
SC 13G/A
Artal International S.C.A.
9 Feb 24
4
PATRICK V.J.J. VINK
15 Jun 23
4
Sapna Srivastava
15 Jun 23
4
AMY W SCHULMAN
15 Jun 23
4
MARC SCHEGERIN
15 Jun 23
4
Klavs F. Jensen
15 Jun 23
4
Pushkal Garg
15 Jun 23
4
Marc Elia
15 Jun 23
4
Bernard Coulie
15 Jun 23